{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:50:32Z","timestamp":1769158232357,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T00:00:00Z","timestamp":1619654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Growing evidence supports a role for extracellular vesicles (EVs) in haemostasis and thrombosis due to exposure of negatively charged procoagulant phospholipids (PPL). Current commercial PPL-dependent clotting assays use chemically phospholipid depleted plasma to measure PPL activity. The purpose of our study was to modify the PPL assay by substituting the chemically phospholipid depleted plasma with PPL depleted plasma obtained by ultracentrifugation This in order to get readily access to a sensitive and reliable assay to measure PPL activity in human plasma and cell supernatants. The performance of the assay was tested, including the influence of individual coagulation factors and postprandial lipoproteins and compared to a commercial PPL assay (STA-Procoag-PPL). The two PPL assays displayed similar sensitivity to exogenously added standardized phospholipids. The PPL activity measured by the modified assay strongly correlates with the results from the commercial assay. The intraday- and between-days coefficients of variation ranged from 2\u20134% depending on the PPL activity in the sample. The modified PPL assay was insensitive to postprandial lipoprotein levels in plasma, as well as to tissue factor (TF) positive EVs from stimulated whole blood. Our findings showed that the modified assay performed equal to the comparator, and was insensitive to postprandial lipoproteins and TF<jats:sup>+<\/jats:sup> EVs.<\/jats:p>","DOI":"10.1038\/s41598-021-88835-y","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T10:05:37Z","timestamp":1619690737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A modified clot-based assay to measure negatively charged procoagulant phospholipids"],"prefix":"10.1038","volume":"11","author":[{"given":"Cathrine","family":"Ramberg","sequence":"first","affiliation":[]},{"given":"S.","family":"Jamaly","sequence":"additional","affiliation":[]},{"given":"N.","family":"Latysheva","sequence":"additional","affiliation":[]},{"given":"L.","family":"Wilsg\u00e5rd","sequence":"additional","affiliation":[]},{"given":"T.","family":"Sovershaev","sequence":"additional","affiliation":[]},{"given":"O.","family":"Snir","sequence":"additional","affiliation":[]},{"given":"J.-B.","family":"Hansen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,4,29]]},"reference":[{"key":"88835_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.thromres.2016.01.011","volume":"139","author":"Y Hisada","year":"2016","unstructured":"Hisada, Y. et al. Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays. Thromb. Res. 139, 90\u201397. https:\/\/doi.org\/10.1016\/j.thromres.2016.01.011 (2016).","journal-title":"Thromb. Res."},{"key":"88835_CR2","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s10753-016-0381-8","volume":"39","author":"AT Halim","year":"2016","unstructured":"Halim, A. T., Ariffin, N. A. & Azlan, M. Review: The multiple roles of monocytic microparticles. Inflammation 39, 1277\u20131284. https:\/\/doi.org\/10.1007\/s10753-016-0381-8 (2016).","journal-title":"Inflammation"},{"key":"88835_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0021-9258(17)34997-9","volume":"166","author":"E Chargaff","year":"1946","unstructured":"Chargaff, E. & West, R. The biological significance of the thromboplastic protein of blood. J. Biol. Chem. 166, 189\u2013197 (1946).","journal-title":"J. Biol. Chem."},{"key":"88835_CR4","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/MBC.0b013e32832ee915","volume":"20","author":"DE Connor","year":"2009","unstructured":"Connor, D. E., Exner, T., Ma, D. D. & Joseph, J. E. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. Blood Coagul. Fibrinolysis 20, 558\u2013564. https:\/\/doi.org\/10.1097\/MBC.0b013e32832ee915 (2009).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"88835_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0304-4157(98)00018-5","volume":"1376","author":"RF Zwaal","year":"1998","unstructured":"Zwaal, R. F., Comfurius, P. & Bevers, E. M. Lipid\u2013protein interactions in blood coagulation. Biochim. Biophys. Acta 1376, 433\u2013453 (1998).","journal-title":"Biochim. Biophys. Acta"},{"key":"88835_CR6","doi-asserted-by":"publisher","first-page":"23247","DOI":"10.1074\/jbc.M111.251769","volume":"286","author":"N Tavoosi","year":"2011","unstructured":"Tavoosi, N. et al. Molecular determinants of phospholipid synergy in blood clotting. J. Biol. Chem. 286, 23247\u201323253. https:\/\/doi.org\/10.1074\/jbc.M111.251769 (2011).","journal-title":"J. Biol. Chem."},{"key":"88835_CR7","doi-asserted-by":"publisher","first-page":"16256","DOI":"10.1016\/S0021-9258(18)98544-3","volume":"266","author":"W Ruf","year":"1991","unstructured":"Ruf, W., Rehemtulla, A., Morrissey, J. H. & Edgington, T. S. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J. Biol. Chem. 266, 16256 (1991).","journal-title":"J. Biol. Chem."},{"key":"88835_CR8","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1161\/01.CIR.96.10.3534","volume":"96","author":"R Nieuwland","year":"1997","unstructured":"Nieuwland, R. et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 96, 3534\u20133541 (1997).","journal-title":"Circulation"},{"key":"88835_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1309\/AJCPGSJ4NHFQMX9W","volume":"137","author":"SD Bohling","year":"2012","unstructured":"Bohling, S. D. et al. comparison of clot-based vs chromogenic factor Xa procoagulant phospholipid activity assays. Am. J. Clin. Pathol. 137, 185\u2013192. https:\/\/doi.org\/10.1309\/AJCPGSJ4NHFQMX9W (2012).","journal-title":"Am. J. Clin. Pathol."},{"key":"88835_CR10","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/MBC.0b013e32832c5e51","volume":"20","author":"P van Dreden","year":"2009","unstructured":"van Dreden, P., Rousseau, A., Fontaine, S., Woodhams, B. J. & Exner, T. Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids. Blood Coagul. Fibrinolysis 20, 494\u2013502. https:\/\/doi.org\/10.1097\/MBC.0b013e32832c5e51 (2009).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"88835_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jacl.2012.06.001","volume":"7","author":"EM Hald","year":"2013","unstructured":"Hald, E. M., Braekkan, S. K., Vik, A., Brodin, E. E. & Hansen, J. B. Postprandial lipemia is not increased in patients with previous unprovoked venous thromboembolism. J. Clin. Lipidol. 7, 48\u201355. https:\/\/doi.org\/10.1016\/j.jacl.2012.06.001 (2013).","journal-title":"J. Clin. Lipidol."},{"key":"88835_CR12","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.thromres.2013.12.022","volume":"133","author":"B Osterud","year":"2014","unstructured":"Osterud, B. & Olsen, J. O. Pro- and anti-inflammatory effects of histamine on tissue factor and TNFalpha expression in monocytes of human blood. Thromb. Res. 133, 477\u2013480. https:\/\/doi.org\/10.1016\/j.thromres.2013.12.022 (2014).","journal-title":"Thromb. Res."},{"key":"88835_CR13","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pathol.2016.10.001","volume":"49","author":"HH Aung","year":"2017","unstructured":"Aung, H. H., Tung, J. P., Dean, M. M., Flower, R. L. & Pecheniuk, N. M. Procoagulant role of microparticles in routine storage of packed red blood cells: Potential risk for prothrombotic post-transfusion complications. Pathology 49, 62\u201369. https:\/\/doi.org\/10.1016\/j.pathol.2016.10.001 (2017).","journal-title":"Pathology"},{"key":"88835_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1538-7836.2011.04610.x","volume":"10","author":"R Lacroix","year":"2012","unstructured":"Lacroix, R. et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: Towards standardization of protocol. J. Thromb. Haemost. 10, 437\u2013446. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04610.x (2012).","journal-title":"J. Thromb. Haemost."},{"key":"88835_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.thromres.2017.04.019","volume":"156","author":"AK Enjeti","year":"2017","unstructured":"Enjeti, A. K., Ariyarajah, A., D\u2019Crus, A., Seldon, M. & Lincz, L. F. Circulating microvesicle number, function and small RNA content vary with age, gender, smoking status, lipid and hormone profiles. Thromb. Res. 156, 65\u201372. https:\/\/doi.org\/10.1016\/j.thromres.2017.04.019 (2017).","journal-title":"Thromb. Res."},{"key":"88835_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ajh.23590","volume":"89","author":"M Marchetti","year":"2014","unstructured":"Marchetti, M. et al. Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia. Am. J. Hematol. 89, 68\u201373. https:\/\/doi.org\/10.1002\/ajh.23590 (2014).","journal-title":"Am. J. Hematol."},{"key":"88835_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.thromres.2017.06.013","volume":"156","author":"A Wannez","year":"2017","unstructured":"Wannez, A. et al. Eculizumab decreases the procoagulant activity of extracellular vesicles in paroxysmal nocturnal hemoglobinuria: A pilot prospective longitudinal clinical study. Thromb. Res. 156, 142\u2013148. https:\/\/doi.org\/10.1016\/j.thromres.2017.06.013 (2017).","journal-title":"Thromb. Res."},{"key":"88835_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1160\/TH15-04-0286","volume":"115","author":"E Campello","year":"2016","unstructured":"Campello, E. et al. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S. Thromb. Haemost. 115, 81\u201388. https:\/\/doi.org\/10.1160\/TH15-04-0286 (2016).","journal-title":"Thromb. Haemost."},{"key":"88835_CR19","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1634\/theoncologist.2017-0530","volume":"23","author":"K Syrigos","year":"2018","unstructured":"Syrigos, K. et al. Prospective assessment of clinical risk factors and biomarkers of hypercoagulability for the identification of patients with lung adenocarcinoma at risk for cancer-associated thrombosis: The observational ROADMAP-CAT Study. Oncologist 23, 1372\u20131381. https:\/\/doi.org\/10.1634\/theoncologist.2017-0530 (2018).","journal-title":"Oncologist"},{"key":"88835_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/ijlh.12773","volume":"40","author":"A Silveira","year":"2018","unstructured":"Silveira, A. et al. VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia. Int. J. Lab. Hematol. 40, 251\u2013257. https:\/\/doi.org\/10.1111\/ijlh.12773 (2018).","journal-title":"Int. J. Lab. Hematol."},{"key":"88835_CR21","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1055\/s-0038-1642021","volume":"2","author":"M Mork","year":"2018","unstructured":"Mork, M. et al. Postprandial increase in blood plasma levels of tissue factor-bearing (and other) microvesicles measured by flow cytometry: Fact or artifact?. TH Open 2, e147\u2013e157. https:\/\/doi.org\/10.1055\/s-0038-1642021 (2018).","journal-title":"TH Open"},{"key":"88835_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","volume":"38","author":"SP Grover","year":"2018","unstructured":"Grover, S. P. & Mackman, N. Tissue factor: An essential mediator of hemostasis and trigger of thrombosis. Arterioscler. Thromb. Vasc. Biol. 38, 709\u2013725. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309846 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"88835_CR23","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1160\/TH05-06-0426","volume":"94","author":"JE Rectenwald","year":"2005","unstructured":"Rectenwald, J. E. et al. D-dimer, P-selectin, and microparticles: Novel markers to predict deep venous thrombosis A pilot study. Thromb. Haemost. 94, 1312\u20131317. https:\/\/doi.org\/10.1160\/TH05-06-0426 (2005).","journal-title":"Thromb. Haemost."},{"key":"88835_CR24","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.jacc.2004.12.075","volume":"45","author":"JA Chirinos","year":"2005","unstructured":"Chirinos, J. A. et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J. Am. Coll. Cardiol. 45, 1467\u20131471 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"88835_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/jth.12268","volume":"11","author":"R Lacroix","year":"2013","unstructured":"Lacroix, R., Dubois, C., Leroyer, A. S., Sabatier, F. & Dignat-George, F. Revisited role of microparticles in arterial and venous thrombosis. J. Thromb. Haemost. 11, 24\u201335. https:\/\/doi.org\/10.1111\/jth.12268 (2013).","journal-title":"J. Thromb. Haemost."},{"key":"88835_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1373\/clinchem.2005.057414","volume":"52","author":"PM van der Zee","year":"2006","unstructured":"van der Zee, P. M. et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. Clin. Chem. 52, 657\u2013664. https:\/\/doi.org\/10.1373\/clinchem.2005.057414 (2006).","journal-title":"Clin. Chem."},{"key":"88835_CR27","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1182\/blood-2013-04-460139","volume":"122","author":"JE Geddings","year":"2013","unstructured":"Geddings, J. E. & Mackman, N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood 122, 1873\u20131880. https:\/\/doi.org\/10.1182\/blood-2013-04-460139 (2013).","journal-title":"Blood"},{"key":"88835_CR28","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1055\/s-0030-1267043","volume":"36","author":"J Rak","year":"2010","unstructured":"Rak, J. Microparticles in cancer. Semin. Thromb. Hemost. 36, 888\u2013906. https:\/\/doi.org\/10.1055\/s-0030-1267043 (2010).","journal-title":"Semin. Thromb. Hemost."},{"key":"88835_CR29","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.thromres.2008.10.016","volume":"123","author":"AE Michelsen","year":"2009","unstructured":"Michelsen, A. E. et al. Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state. Thromb. Res. 123, 881\u2013886. https:\/\/doi.org\/10.1016\/j.thromres.2008.10.016 (2009).","journal-title":"Thromb. Res."},{"key":"88835_CR30","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1161\/01.ATV.0000249639.36915.04","volume":"26","author":"G Chironi","year":"2006","unstructured":"Chironi, G. et al. Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler. Thromb. Vasc. Biol. 26, 2775\u20132780. https:\/\/doi.org\/10.1161\/01.ATV.0000249639.36915.04 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"88835_CR31","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.2337\/diabetes.51.9.2840","volume":"51","author":"F Sabatier","year":"2002","unstructured":"Sabatier, F. et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51, 2840\u20132845 (2002).","journal-title":"Diabetes"},{"key":"88835_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1055\/s-0035-1564044","volume":"41","author":"JM Gajsiewicz","year":"2015","unstructured":"Gajsiewicz, J. M. & Morrissey, J. H. Structure\u2013function relationship of the interaction between tissue factor and factor VIIa. Semin. Thromb. Hemost. 41, 682\u2013690. https:\/\/doi.org\/10.1055\/s-0035-1564044 (2015).","journal-title":"Semin. Thromb. Hemost."},{"key":"88835_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2017.11.006","author":"A Kaminska","year":"2017","unstructured":"Kaminska, A., Enguita, F. J. & Stepien, E. L. Lactadherin: An unappreciated haemostasis regulator and potential therapeutic agent. Vascul. Pharmacol. https:\/\/doi.org\/10.1016\/j.vph.2017.11.006 (2017).","journal-title":"Vascul. Pharmacol."},{"key":"88835_CR34","doi-asserted-by":"publisher","first-page":"e0142835","DOI":"10.1371\/journal.pone.0142835","volume":"10","author":"C Gao","year":"2015","unstructured":"Gao, C. et al. Thrombotic role of blood and endothelial cells in uremia through phosphatidylserine exposure and microparticle release. PLoS ONE 10, e0142835. https:\/\/doi.org\/10.1371\/journal.pone.0142835 (2015).","journal-title":"PLoS ONE"},{"key":"88835_CR35","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/01.mbc.0000061366.73802.df","volume":"14","author":"T Exner","year":"2003","unstructured":"Exner, T., Joseph, J., Low, J., Connor, D. & Ma, D. A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid. Blood Coagul. Fibrinolysis 14, 773\u2013779. https:\/\/doi.org\/10.1097\/01.mbc.0000061366.73802.df (2003).","journal-title":"Blood Coagul. Fibrinolysis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88835-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88835-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88835-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T07:27:21Z","timestamp":1670052441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88835-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88835"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88835-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,29]]},"assertion":[{"value":"17 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9341"}}